April 15 (Reuters) - Kadimastem Ltd KDST.TA:
NLS PHARMACEUTICS ANNOUNCES POSITIVE RESULTS FROM STUDY KO-943 DEMONSTRATING MAZINDOL REDUCES FENTANYL-INDUCED REWARD IN ANIMAL MODELS
Source text: ID:nPn53Yxtfa
Further company coverage: KDST.TA
((Reuters.Briefs@thomsonreuters.com;))